total operating expenses varied in line with the company’s revenue. Comparing the total revenue and the total operating expenses in Q2–2019 with Q1–2019 and Q2-2018, it showed that the change rate had

Q3–2018 and Q2–2018 and Q3–2017, it found that the change rate was decreasing in the same direction and very close ratio. In Q3–2018, the Company’s profit slightly decreased compared to Q2–2018

busine m Japan proj increased by sued B/E an f Baht 2,362 s the Co-Gener ofit from inve aht 51.23 mil period of las past service from 300 to 4 d administrat change rate lo aht 33.30 mill used by WPS

profi rison to profi %. from investm 101.59 millio change rate lo Baht 21.93 nt the unreali aht 79.19 mill or 69.40% fr ,479.10 milli n, which has t and Vietnam ht 41.83 millio m. ration Combi it from

results for the six-month period of 2019, change of rate more than 20 percent Dear Director and Manager The Stock Exchange of Thailand According to the resolution of the Board of Directors of DOD Biotech

results for the nine-month period of 2019, change of rate more than 20 percent Dear Director and Manager The Stock Exchange of Thailand According to the resolution of the Board of Directors of DOD Biotech

. OCMSET / 1905/002 May 8, 2019 Subject: Clarification of the operating results for the three-month period of 2019, change of rate more than 20 percent Dear Director and Manager the Stock Exchange of

line with the company’s revenue. Comparing the total revenue and the total operating expenses in Q3–2019 with Q2–2019 and Q3-2018 showed that the change rate had increased in the same direction and with

extension of the maturity date for redemption for three years (SABUY258A);    (7) A change to the interest rate for each period to 2-7 percent per year, effective from 20 November 2024 until the new

.  Pattaragit Netiniyom, researcher, Faculty of Business Administration, Kasetsart University revealed the result of study on changes in 9 variables including the rate of change in gross profit, liabilities